As of 2024-12-12, the EV/EBITDA ratio of Asensus Surgical Inc (ASXC) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASXC's latest enterprise value is 87.93 mil USD. ASXC's TTM EBITDA according to its financial statements is -75.08 mil USD. Dividing these 2 quantities gives us the above ASXC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 23.3x | 21.2x |
| Forward P/E multiples | 21.7x - 27.3x | 24.0x |
| Fair Price | (5.93) - (6.39) | (6.19) |
| Upside | -1805.8% - -1935.5% | -1878.2% |
| Date | EV/EBITDA |